ATRX loss induces multiple hallmarks of the alternative lengthening of telomeres (ALT) phenotype in human glioma cell lines in a cell line-specific manner
Jacqueline A. Brosnan‐Cashman(Johns Hopkins University), Alan K. Meeker(Johns Hopkins University), David Esopi(AstraZeneca (United States)), Mindy K. Graham(Johns Hopkins University), Kaylar M. Myers(Johns Hopkins University), Ming Yuan(Heilongjiang Provincial Academy of Agricultural Sciences), Eric H. Raabe(Johns Hopkins University), Christopher M. Heaphy(Boston University), Rebecca Zhang(Johns Hopkins University), Christine Davis(Johns Hopkins University), Anthony Rizzo(Johns Hopkins University), Charles G. Eberhart(The University of Texas MD Anderson Cancer Center)
Cited by 71
Related Papers
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
|Proceedings of the National Academy of Sciences|2013|1.4k
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Altered Telomeres in Tumors with <i>ATRX</i> and <i>DAXX</i> Mutations
|Science|2011|1.1k
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|711